The Relationship Between the Reward and Stress Systems and How They are Perturbed in Addiction
|
|
|
- Natalie Fisher
- 9 years ago
- Views:
Transcription
1 The Relationship Between the Reward and Stress Systems and How They are Perturbed in Addiction George F. Koob, Ph.D. Professor and Chair Committee on the Neurobiology of Addictive Disorders The Scripps Research Institute La Jolla, California Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology Reviews 35 (2010) Koob GF. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. In: Spanagel R, Sommer W (eds) Behavioral Neurobiology of Alcohol Addiction (series title: Current Topics in Behavioral Neuroscience, 2013 Vol. 13), Springer, New York, pp Learning Objectives 1. Understand a conceptual framework of addiction that goes beyond the acute rewarding effects of drugs 2. Understand the neuroplasticity in the brain reward, stress systems and executive function systems associated with the transition to addiction 3. Understand how such knowledge may predict vulnerability and novel treatments for addiction 1
2 Stress and Reward: The Two Faces of Janus Bottom lines 1. Addiction is an incentive salience disorder 2. Addiction is a reward deficit disorder 3. Addiction is a stress surfeit disorder 4. Addiction is a self-regulation disorder 2
3 Addiction Addiction can be defined as a chronically relapsing disorder that is characterized by a compulsion to seek and take drug or stimulus, loss of control in limiting intake, and emergence of a negative emotional state (e.g. dysphoria, anxiety, irritability) when access to the drug or stimulus is prevented (here, defined as the dark side of addiction) Theoretical Framework Relating Addiction Cycle to Motivation for Drug Seeking From: Koob GF. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. In: Spanagel R, Sommer W (eds) Behavioral Neurobiology of Alcohol Addiction (series title: Current Topics in Behavioral Neuroscience), Springer, New York, in press. 3
4 Positive and Negative Reinforcement- Definitions Positive Reinforcement defined as the process by which presentation of a stimulus (drug) increases the probability of a response (non dependent drug taking paradigms). Negative Reinforcement defined as a process by which removal of an aversive stimulus (negative emotional state of drug withdrawal) increases the probability of a response (dependence-induced drug taking) Stages of the Addiction Cycle 4
5 Non Drug Process Addiction Cycles Drug Addiction Compulsive Exercise Compulsive Shopping Compulsive Gambling Compulsive Eating Compulsive Sex Neurobiology of Addiction From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010)
6 Binge-Intoxication Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology Reviews 35 (2010)
7 Effects of Cocaine and Amphetamine on Dopamine Synaptic Function Mesolimbic Dopamine System Mesolimbic dopamine system 1. Ventral tegmental area 2. Nucleus accumbens Nucleus Accumbens Ventral Tegmental Area (VTA) 7
8 Cocaine Self-Administration From: Caine SB, Lintz R and Koob GF. in Sahgal A (ed) Behavioural Neuroscience: A Practical Approach, vol. 2, IRL Press, Oxford, 1993, pp Pieter Bruegel 8
9 Opioid Peptide Reward System Enkephalin and endorphin reward system 1. Ventral tegmental area 2. Nucleus accumbens 3. Amygdala Nucleus Accumbens Amygdala Ventral Tegmental Area (VTA) Alcohol Consumption Induces Endogenous Opioid Release in the Human Nucleus Accumbens From: Mitchell JM, O Neil JP, Janabi M, Marks SM, Jagust WJ, Fields HL. Sci Transl Med, 2012, 4:116ra6. 9
10 Converging Acute Actions of Drugs of Abuse on the Ventral Tegmental Area and Nucleus Accumbens From: Nestler EJ, Nat Neurosci, 2005, 8: Neurocircuitry of Incentive Salience The Ventral to Dorsal Striatal Shift: Ascending Spirals of VTA/Nigra-Striatal pathways goal-directed drug seeking & taking pavlovian conditioning drug seeking & taking habits vulnerability abstinence/ relapse compulsive drug seeking Everitt & Robbins 2005 Ikemoto similar organization in rat brain Haber et al
11 template "Absinthe Drinker" Pablo Picasso (1910) Withdrawal-Negative Affect Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology Reviews 35 (2010)
12 Standard Pattern of Affective Dynamics Produced by Novel and Repeated Unconditioned Stimulus or Opponent Process: What Goes Up Must Come Down From: Solomon RL, American Psychologist, 1980, 35: Reward Transmitters Implicated in the Motivational Effects of Drugs of Abuse Positive Hedonic Effects Dopamine Opioid peptides Serotonin GABA Negative Hedonic Effects of Withdrawal Dopamine dysphoria Opioid peptides... pain Serotonin dysphoria GABA anxiety, panic attacks 12
13 Decreased Dopamine D 2 Receptor Activity in a Cocaine Abuser From: Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey S and Wolf AP, Synapse, 1993, 14: CNS Actions of Corticotropin-Releasing Factor (CRF) 13
14 Rodent Model of Excessive Drinking During Withdrawal Self-administration training Dependence induction Withdrawal from alcohol vapors Negative emotional state: Anxiety-like behavior Reward threshold deficits Increased CRF release in the extended amygdala Sweetened solution fading used to train animals to lever press for: 10%w/v EtOH vs Water Chronic intermittent alcohol vapors (4+ wks) Target blood alcohol levels (BALs): g% Excessive drinking: 2-3 fold higher alcohol intake Increased progressive ratio breakpoints Relapse following prolonged abstinence Methods from: Roberts AJ, Cole M and Koob GF, Alcohol Clin Exp Res, 1996, 20: Roberts AJ, Heyser CJ, Cole M, Griffin P and Koob GF, Neuropsychopharmacology, 2000, 22: O Dell LE, Roberts AJ, Smith RT and Koob GF, Alcohol Clin Exp Res, 2004, 28: Summary of Drugs of Abuse Interactions with Corticotropin-Releasing Factor Systems CRF Antagonist Effects Withdrawal-induced changes in extracellular CRF in CeA Withdrawal-induced anxiety-like or aversive responses Baseline selfadministration or place preference Dependence-induced increases in selfadministration Stress-induced reinstatement Modified from: Swanson LW, Sawchenko PE, Rivier J and Vale W, Neuroendocrinology, 1983, 36: Koob GF, Neuron, 59:
15 Anti-Reward Transmitters Implicated in the Motivational Effects of Drugs of Abuse Dynorphin dysphoria CRF stress Norepinephrine stress Non-dependent Dependent Positive Reinforcement Negative Reinforcement 15
16 Neurobiology of Addiction: Preoccupation- Anticipation ( Craving ) Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) Loss of Control Over Intake Self-medication Cause Neuron/oligodendrocyte death VTA CRF Neurons? PFC DA/NE? Initial intake PFC CRF/GABA interneurons Withdrawal 16
17 Medications Development- A Rosetta Stone Approach From: Koob GF, Lloyd GK, Mason BJ. Nat Rev Drug Discovery, 2009, 8: Future Targets for Medications Development Derived from Preclinical Basic Research Class Dopamine receptor partial agonists Target D 2 receptor partial agonist (aripiprazole) D 3 receptor partial agonist Modulators of g-aminobutyric acid Gabapentin Modulators of brain stress systems CRF 1 receptor antagonist Dynorphin antagonist Neurokinin-1 receptor antagonist Modulators of glutamate AMPA receptor antagonist NMDA receptor antagonist Metabotropic glutamate receptor agonist Glutamate-5 receptor antagonist Topiramate From: Koob GF, Lloyd GK, Mason BJ. Nat Rev Drug Discov, 2009, 8:
18 Bottom lines 1. Addiction is a facilitation of incentive salience - compulsive drug taking is associated with engagement of associative (stimulus response) mechanisms involving cortico-striatal-pallidal-thalamic loops that converge in the basal ganglia 2, Addiction is a reward deficit disorder- all drugs of abuse compromise reward function and decrease dopamine activity 3. Addiction is a stress surfeit disorder- all drugs of abuse sensitize brain stress systems such as CRF 4. Addiction is an executive system disorder- all drugs of abuse compromise frontal cortical executive function which disinhibits impulsivity and disinhbits the brain stress systems Learning Objectives 1. Understand a conceptual framework of addiction that goes beyond the acute rewarding effects of drugs 2. Understand the neuroplasticity in the brain reward, stress systems and executive function systems associated with the transition to addiction 3. Understand how such knowledge may predict vulnerability and novel treatments for addiction 18
19 Neurobiology of Drug Addiction Koob Laboratory Post-Doctoral Fellows Cindy Funk Brendan Walker Tom Greenwell Sandy Ghozland Chitra Mandyam Dong Ji Candice Contet Laura Orio Kaushik Misra Nick Gilpin Michel Verheij Sunmee Wee Scott Edwards Leandro Vendruscolo Tim Whitfield Joel Schossberg Ami Cohen Carrie Wade Brooke Schmeichel Visiting Professors Choon-Gon Jang Charles Heyser Special Mention Olivier George Prefrontal Cortex, c-fos, CRF, and executive function Support from: Ph.D. Students Paula Park Cara Buck Administrative Assistants Lisa Maturin Mellany Santos Marisa Gallego Staff Scientists Heather Richardson Olivier George Senior Research Assistants Mike Arends Elena Crawford Robert Lintz National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Diabetes and Digestive and Kidney Diseases Pearson Center for Alcoholism and Addiction Research 19
Novel Targets for Treatment from the Dark Side of Dependence: Focus on the Brain Stress Systems
Novel Targets for Treatment from the Dark Side of Dependence: Focus on the Brain Stress Systems George F. Koob, Ph.D. Professor and Chair Committee on the Neurobiology of Addictive Disorders The Scripps
Alcohol, Stress and the Brain
Alcohol, Stress and the Brain George F. Koob, Ph.D. Professor and Chair Committee on the Neurobiology of Addictive Disorders The Scripps Research Institute La Jolla, California Koob GF, A Role for Brain
Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives
Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives Neurobehavioral Aspects of Alcohol Consumption Source: Eighth Special Report to the U.S. Congress on Alcohol and Health Secretary
What Can Science Contribute to the Treatment of Alcoholism?
What Can Science Contribute to the Treatment of Alcoholism? George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Flow of Talk 1. Conceptual Framework
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair Michael Fishman, MD Director of Young Adult Program How Addiction Takes Hold Large & rapid upsurges in dopamine
Overview. Unit 5: How do our choices change our brains?
Unit 5: How do our choices change our brains? Overview In the previous units, we learned about the neuron, synaptic transmission, and neuronal circuits. In this key culminating unit, we ll bring all of
AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS
AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS BARRY J. EVERITT Department of Experimental Psychology, University of Cambridge Stimulant drugs, such as cocaine and amphetamine, interact directly with dopamine
DSM-IV Alcohol Dependence. Alcohol and Drug Abuse. Screening for Alcohol Risk. DSM-IV Alcohol Abuse
DSM-IV Alcohol Dependence Alcohol and Drug Abuse David Gilder, MD Division of Mental Health Scripps Clinic Alcohol Research Center The Scripps Research Institute 1.5.11 Three or more criteria, same 12
The Neurobiology of Addiction. An Overview
The Neurobiology of Addiction An Overview AMANDA J. ROBERTS, PH.D., AND GEORGE F. KOOB, PH.D. Addiction can be defined in part as a compulsion to use alcohol or other drugs and the occurrence of withdrawal
The Addicted Brain. And what you can do
The Addicted Brain And what you can do How does addiction happen? Addiction can happen as soon as someone uses a substance The brain releases a neurotransmitter called Dopamine into the system that makes
Neurobiology and Treatment of Alcohol Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Alcohol Dependence Nebraska MAT Training September 29, 2011 Prior treatment episodes for persons starting treatment for alcohol dependence, 2009 Percent 50 45 40 35 30 25
Drugs, The Brain, and Behavior
Drugs, The Brain, and Behavior John Nyby Department of Biological Sciences Lehigh University What is a drug? Difficult to define Know it when you see it Neuroactive vs Non-Neuroactive drugs Two major categories
Slide 1: Introduction Introduce the purpose of your presentation. Indicate that you will explain how the brain basically works and how and where
Slide 1: Introduction Introduce the purpose of your presentation. Indicate that you will explain how the brain basically works and how and where drugs such as heroin and cocaine work in the brain. Tell
Prevention & Recovery Conference November 28, 29 & 30 Norman, Ok
Prevention & Recovery Conference November 28, 29 & 30 Norman, Ok What is Addiction? The American Society of Addiction Medicine (ASAM) released on August 15, 2011 their latest definition of addiction:
The Future of Treating Alcoholism: Framing the Key Research Questions
The Future of Treating Alcoholism: Framing the Key Research Questions Kathleen A. Grant, Ph.D. President, Research Society on Alcoholism A Society of basic, clinical and translation researchers committed
WHAT HAPPENS TO OUR BRAIN?
WORK DYNAMIC The final result of this session is the formulation of the questions that, within the activity of the Let s talk about drugs programme of the la Caixa Welfare Project, you will ask Dr. Rafael
American Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement: Definition of Addiction (Long Version) Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry.
Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; 2004. NIH Publication No. 04-3769.
Diagnosis and Treatment of Alcohol Dependence Lon R. Hays, MD, MBA Professor and Chairman an Department of Psychiatry University of Kentucky Medical Center Defining the Standard Drink A standard drink
Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; 2004. NIH Publication No. 04-3769.
Diagnosis and Treatment of Alcohol Dependence Lon R. Hays, MD, MBA Professor and Chairman Department of Psychiatry University of Kentucky Medical Center Defining the Standard Drink A standard drink = 14
Addiction Neurobiology
Addiction Neurobiology Stephen Jurd University of Sydney Australia Richard W is sick Apology The site of pathology IF Addiction has a neurobiological basis THEN we should be able to: Define addiction AND
SC 215 FIGHTING DRUG ADDICTION WITH DRUGS. John Bush April 15, 2013
SC 215 FIGHTING DRUG ADDICTION WITH DRUGS John Bush April 15, 2013 ADDICTION A persistent, compulsive dependence on a behavior or substance Behavioral Compulsive shopping --Compulsive eating Compulsive
Alcohol Overuse and Abuse
Alcohol Overuse and Abuse ACLI Medical Section CME Meeting February 23, 2015 Daniel Z. Lieberman, MD Professor and Vice Chair Department of Psychiatry George Washington University Alcohol OVERVIEW Definitions
NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH
NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH Disclosures This presentation does not represent the views of the US Public Health Service or the US Food and Drug Administration The majority
Alcoholism, like addiction to other drugs, is a chronic, THE POTENTIAL OF NEUROSCIENCE TO INFORM TREATMENT. George F. Koob, Ph.D.
THE POTENTIAL OF NEUROSCIENCE TO INFORM TREATMENT George F. Koob, Ph.D. In the 40 years since the founding of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), researchers have gained a better
The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction.
The Brain, Behavior, and Addiction Flo Hilliard University of Wisconsin-Madison Division of Continuing Studies Objectives Progress of science in addiction studies Why it is a brain disease Changing our
Introduction to Tolerance, Physical Dependence and Withdrawal
Introduction to Tolerance, Physical Dependence and Withdrawal Carrie G Markgraf, MD, PhD Safety Assessment Merck Research Laboratories 1 Overview Definitions Addiction, psychological dependence, physical
EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
THE BRAIN & DRUGS. Nebraska Training on Substance Abuse Prevention
THE BRAIN & DRUGS Nebraska Training on Substance Abuse Prevention Educational Service Unit 10 Building 76 Plaza Blvd., Kearney, NE 68848-0850 Tuesday, April 26th 2011 MODULE 2 1 Overview How does the brain
The Science of Addiction:
The Science of Addiction: Why it s a bad idea to turn to drugs in times of stress Regina M. Carelli, PhD Stephen B. Baxter Distinguished Professor Department of Psychology & Neuroscience The University
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
Systematic Review of Treatment for Alcohol Dependence
Systematic Review of Treatment for Alcohol Dependence ALCOHOL ARCUATE NUCLEUS in Hypothalamus, pituitary Beta-endorphin Dynorphin Kappa receptor Nucleus Enkephalins accumbens Delta receptor (+) Mu receptor
7/29/2013. Pleasure Unwoven: An Adventure in Social Marketing. Choice vs. Disease. Kevin McCauley, MD Texas Behavioral Health Insistute July 2013
Pleasure Unwoven: An Adventure in Social Marketing Kevin McCauley, MD Texas Behavioral Health Insistute July 2013 Choice vs. Disease 1 PILOTS! HMH-363 Red Lions MCAS Tustin, CA 2 U.S. Navy Sober Living
Tolerance and Dependence
Tolerance and Dependence Drug Tolerance is a decrease in the effect of a drug as a consequence of repeated exposure. Change over repeated exposures. Different effects may show different tolerance. Tolerance
Beroendemekanismer- ett beroende som andra?
Beroendemekanismer- ett beroende som andra? Neuroendokrina responser till spel om pengar Anna Söderpalm Gordh Dopamine and the Rewardsystem Studies in animal models have demonstrated that mesocorticolimbic
Chronic Stress, Drug Use, and Vulnerability to Addiction
Chronic Stress, Drug Use, and Vulnerability to Addiction Rajita Sinha Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA Stress is a well-known risk factor in the
Drugs of abuse (including alcohol)
Addiction: Beyond dopamine reward circuitry Nora D. Volkow a,b,1, Gene-Jack Wang c, Joanna S. Fowler c, Dardo Tomasi b, and Frank Telang b a National Institute on Drug Abuse, National Institutes of Health,
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community Dr David Jackson Clinic Medical Officer The Hobart Clinic Association Drugs In tonight s context, drugs
The latest in addiction medicine: What every nurse needs to know
CNA Webinar Series: Progress in Practice The latest in addiction medicine: What every nurse needs to know Monica Gregory Nurse Practitioner, Crosstown Clinic December 4, 2014 Canadian Nurses Association,
LESSON 5.7 WORKBOOK Is addiction a chronic disease?
DEFINITIONS OF TERMS Addiction is a disease idea that states drug addiction is no different from other chronic diseases, like diabetes and heart disease, and thus needs to be treated as a distinct medical
substance abuse and addiction are complex phenomena
Executive Summary 1 substance abuse and addiction are complex phenomena that defy simple explanation or description. A tangled interaction of factors contributes to an individual s seeking out, using,
ADOLESCENT BRAIN DEVELOPMENT: IMPLICATIONS FOR DRUG USE PREVENTION. Jessie Breyer, B.A. & Ken C. Winters, Ph.D. Center for Substance Abuse Research
ADOLESCENT BRAIN DEVELOPMENT: IMPLICATIONS FOR DRUG USE PREVENTION Jessie Breyer, B.A. & Ken C. Winters, Ph.D. Center for Substance Abuse Research Department of Psychiatry, University of Minnesota & Mentor
The Limbic System Theory of Addiction
The Limbic System Theory of Addiction The brain controls every aspect of a human being. From breathing to blinking, it runs the show. Most of how it operates, however, is on an automatic and unconscious
Neuroadaptive mechanisms of addiction: studies on the extended amygdala
European Neuropsychopharmacology 13 (2003) 442 452 www.elsevier.com/locate/euroneuro Neuroadaptive mechanisms of addiction: studies on the extended amygdala George F. Koob* Division of Psychopharmacology,
Understanding Addiction: The Intersection of Biology and Psychology
Understanding Addiction: The Intersection of Biology and Psychology Robert Heimer, Ph.D. Yale University School of Public Health Center for Interdisciplinary Research on AIDS New Haven, CT, USA November
ASSIGNMENTS AND GRADING
Instructor: Janet Menard Office: Craine- 431 Phone: 533-3099 Email: [email protected] Class Hours: Tuesdays 11:30 1:00 Friday 1:00 2:30 Office Hours: Mondays 1:00-2:00 Thursdays 3:30-4:30 (please notify
1. According to recent US national estimates, which of the following substances is associated
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
Addiction Medicine 2014
Addiction Medicine 2014 Update on Current/New/Anticipated Medications for Alcohol Use Disorders J.C. Garbutt, MD Department of Psychiatry and Bowles Center for Alcohol Studies School of Medicine, University
Drug Addiction glutamate dysfunction, treatments, biomarkers. Peter Kalivas Department of Neurosciences Medical University of So Carolina Charleston
Drug Addiction glutamate dysfunction, treatments, biomarkers Peter Kalivas Department of Neurosciences Medical University of So Carolina Charleston What is Addiction? Inability to control drug-seeking
Understanding Addiction: Squirrel Logic
Understanding Addiction: Squirrel Logic Brad Lander PhD, LICDC Clinical Director / Psychologist Talbot Hall Addiction Medicine at The Ohio State University Wexner Medical Center Addiction Lack of ability
Drug Addiction, Dysregulation of Reward, and Allostasis George F. Koob, Ph.D., and Michel Le Moal, M.D., Ph.D.
PERSPECTIVES Drug Addiction, Dysregulation of Reward, and Allostasis George F. Koob, Ph.D., and Michel Le Moal, M.D., Ph.D. This paper reviews recent developments in the neurocircuitry and neurobiology
Alcoholism In The Office SCOTT PAIST, III, M. D.
Alcoholism In The Office SCOTT PAIST, III, M. D. The Dopaminergic Mesolimbic System PFC= Prefrontal Cortex NA=Nucleus Accumbens VTA= Ventral Tegemntal Area A = Amygdala C = Caudate Nucleus The Limbic System
MOLECULAR AND CELLULAR BIOLOGY OF ADDICTION
96 MOLECULAR AND CELLULAR BIOLOGY OF ADDICTION KATHY L. KOPNISKY STEVEN E. HYMAN Addiction to alcohol, tobacco, and illegal drugs represents a substantial burden to societies worldwide. In terms of health-related
Addiction, OCD, & riding a bike: how opiates control your brain
Addiction, OCD, & riding a bike: how opiates control your brain Shay Neufeld PhD candidate, neuroscience April 22nd, 2015 1. What are opiates? what you are in for 2. Where is opiate addiction in the brain?
Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania
Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective
Sponsored by: 2013 NAMI Maryland Conference Baltimore, Maryland; Friday, October 18 th, 2013
Integrated System of Care Universal Dual Diagnosis Capabilities Principles of Empathy and Hope Motivational Interviewing Approach Stages of Change Model Design Solution Focused Strength Based Skill Building
Dr. Joseph Frascella
Dr. Joseph Frascella WHY YOU CAN T JUST SAY NO : Combatting Drug Addiction is Harder Than You Might Think The frontal areas of the young brain develop last. Those do the more executive function the inhibitory
How To Know If You Can Get Over Your Head With Exercise
Page 1 of 9 Endorphins, Exercise, and Addictions: A Review of Exercise Dependence Andrea Leuenberger 1 1 Lafayette College, Easton, PA 18042 Endorphins are endogenous opioids released from the pituitary
Alchemy -Neuroscience of Alcoholism
Neuroscience of Alcohol Addiction David W. Oslin, MD Associate Professor University of Pennsylvania, School of Medicine And Philadelphia, VAMC Hazelden Research Co-Chair on Late Life Addictions Introduction
The Neuropharmacology of Drugs of Abuse 3
The Neuropharmacology of Drugs of Abuse 3 rugs of abuse interact with the neurochemical mechanisms of the brain. Some of these interactions are directly related to the reinforcing properties of a drug,
Hilary J. Little, Ph.D.
Behavioral Mechanisms Underlying the Link Between Smoking and Drinking Hilary J. Little, Ph.D. Many people use both alcohol and nicotine (i.e., cigarettes and other tobacco products). The behavioral effects
The Developing Brain, Adolescence and Vulnerability to Drug Abuse
Welcome. This presentation is for you to read and to use in your prevention work. We hope you will review it, learn from it and feel comfortable using it in presentations to colleagues that work in prevention,
Addiction: The New Definition from the American Society of Addiction Medicine (ASAM)
Addiction: The New Definition from the American Society of Addiction Medicine (ASAM) Mississippi Society of Addiction Medicine Jackson, Mississippi February, 2012 Michael M. Miller, MD, FASAM, FAPA [email protected]
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
NEUROBIOLOGY OF CANNABIS ADDICTION Part I
NEURBILGY F CANNABIS ADDICTIN Part I 1. Definition and mechanism of action of cannabinoids 2. Addictive potential of cannabinoids and mechanisms involved 3. Cognitive effects of cannabinoids and mechanisms
Naltrexone and Alcoholism Treatment Test
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
Robert Walker, M.S.W., L.C.S.W., Assistant Professor University of Kentucky
The Neuroscience of Addiction Robert Walker, M.S.W., L.C.S.W., Assistant Professor University of Kentucky Center on Drug and Alcohol Research Why do we need the science on addiction i for community projects?
4/13/2011. 5 Actions to Overcome Addiction. John Fitzgerald, PhD, LPC, CAS. relationships
5 Actions to Overcome Addiction John Fitzgerald, PhD, LPC, CAS relationships 1 What is addiction? 2 Socially-constructed 3 Risk Factors 80% 15 years-old Addiction Protective Factors Risk Factors Domain
DrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
OVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
PERSPECTIVES. Opiate versus psychostimulant addiction: the differences do matter FOCUS ON ADDICTION
FOCUS ON ADDICTION PERSPECTIVES OPINION Opiate versus psychostimulant addiction: the differences do matter Aldo Badiani, David Belin, David Epstein, Donna Calu and Yavin Shaham Abstract The publication
Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation
Advanced Treatment for Opioid & Alcohol Dependence John Larson, M.D. Corporate Medical Director Gateway Foundation Background 41 years practicing psychiatry Last 15 in addiction medicine I ve watched a
The Science of Addiction and Its Effective Treatment
The Science of Addiction and Its Effective Treatment Anne Arundel County Opioid Misuse and Overdose Symposium April 15, 2015 D. Andrew Tompkins, M.D. M.H.S. Agenda 1. Terminology a. Addiction versus Substance
Gabapentin Treatment for Alcohol Dependence: A Randomized Clinical Trial
Gabapentin Treatment for Alcohol Dependence: A Randomized Clinical Trial Barbara J. Mason, Ph.D. Professor, Committee on the Neurobiology of Addictive Disorders Director, Laboratory of Clinical Psychopharmacology
Martha Brewer, MS, LPC,LADC. Substance Abuse and Treatment
Martha Brewer, MS, LPC,LADC Substance Abuse and Treatment What is a substance use disorder? Long-term and chronic illness Can affect anyone: rich or poor, male or female, employed or unemployed, young
fmri studies of addiction and relapse Rebecca Elliott Bill Deakin Anna Murphy Neuroscience and Psychiatry Unit
fmri studies of addiction and relapse Rebecca Elliott Bill Deakin Anna Murphy Neuroscience and Psychiatry Unit Background Previous PhD projects on brain basis of craving: Lesley Peters and Dan Lubman Expertise
Until now, all the chapters of this book have addressed how psychotropic drugs affect
CHAPTER 19 Disorders of Reward, and Thei r Treatment Drug Abuse, III Reward circuits!ill Nicotine III Alcohol III Opiates II Stimulants III Sedative hypnotics III Marijuana III Hallucinogens III Club drugs
Addictions: Why Don t They Just Quit?
Counseling Center of New Smyrna Beach 265 N. Causeway New Smyrna Beach FL 32169 Ph: 386-423-9161 Fax: 386-423-3094 Addictions: Why Don t They Just Quit? By Shane Porter One of the most frustrating issues
Curriculum Vitae Cassandra Gipson Arizona State University Psychology Department
Curriculum Vitae Cassandra Gipson Arizona State University Department Education 2004 Bachelor of Science in, University of California, San Diego 2007 Master of Science in, Thesis: Post-Choice Stimulus
Neurobiology and pharmacology of psychostimulants
Department of Toxicology,University of Cagliari ; Institute of Neuroscience,CNR Centre for Studies on the Neurobiology of Dependence, MURST Neurobiology and pharmacology of psychostimulants Gaetano Di
Addiction and the Brain's Pleasure Pathway: Beyond Willpower
Addiction and the Brain's Pleasure Pathway: Beyond Willpower The human brain is an extraordinarily complex and fine-tuned communications network containing billions of specialized cells (neurons) that
Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface
Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface Kathleen Brady, M.D., Ph.D. Professor of Psychiatry Associate Dean of Clinical and Translational Research Medical University
What Is Craving? Raymond F. Anton, M.D.
What Is Craving? Models and Implications for Treatment Raymond F. Anton, M.D. Although many alcoholics experience craving, researchers have not yet developed a common, valid definition of the phenomenon.
